Display Settings:

Format

Send to:

Choose Destination
    Acta Myol. 2007 Jul;26(1):53-7.

    McArdle disease: molecular genetic update.

    Source

    Dept. Patologia Mitocondrial i Neuromuscular, Centre d'Investigacions en Bioquímica i Biología Molecular (CIBBIM), Institut de Recerca Vall d'Hebron, Barcelona, Spain. aandreu@ir.vhebron.net

    Abstract

    McArdle disease or Glycogenosis type V is an autosomal recessive metabolic disorder caused by a deficiency of the muscle isoform of glycogen phosphorylase (myophosphorylase, PYGM), the specific skeletal muscle enzyme that initiates glycogen breakdown. Since the first clinical description by Brian McArdle in 1951, several patients have been identified worldwide and significant advances have been made in the study of molecular genetics of the disease. Molecular heterogeneity has been demonstrated by the identification to date of more than 65 mutations in the PYGM gene.

    PMID:
    17915571
    [PubMed - indexed for MEDLINE]
    PMCID: PMC2949323
    Free PMC Article

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk